Conversa recognized for its automated care coordination, efficient care navigation and patient experience
CB Insights, a technology market intelligence company, issued a new report ranking Conversa Health tops in the “leader” category of its analysis of companies providing artificial intelligence-enabled chatbots for self-triage. Conversa scored highest in CB Insights’ analysis on both “ability to execute” and “market strength.”
Automated self-triage chatbots save time for physicians and call centers, engage patients and more accurately route them for care, CB Insights said in its report. This need became even more critical during the COVID-19 pandemic. Conversa was one of the first companies to develop a suite of COVID-19 Virtual Care Solutions, helping hospitals increase capacity by automating the outreach to, and monitoring of, vulnerable patient and employee populations. CB Insights reviewed hundreds of healthcare technology companies to define the category for this report.
Innovators turn to automated virtual care
Conversa’s Automated Virtual Care and Triage™ platform enables health systems to remotely monitor, analyze and communicate with patients and healthcare consumers at scale—for chronic care, post-acute, perioperative, oncology, OBGYN, prevention and wellness, and many other use cases. The platform automates care where possible, identifies at-risk patients and provides them digital triage to higher levels of care when necessary, e.g., phone calls, telehealth, e-visits or scheduling in-person consults.
Leading health systems, including UCSF Health, Northwell Health, UNC Health, Prisma Health, SCL Health, University Hospitals and El Camino Health, have experienced significant clinical and operational benefits that include improved patient satisfaction, engagement and care plan adherence, reduced hospital readmissions, lower procedure no-show/cancellation rates, and better care team coordination and productivity.
Prisma Health, an 18-hospital system serving South Carolina, adopted Conversa’s COVID-19 Health Screener and Triage Program in April 2020. Using Conversa, Prisma reduced in-person evaluations for COVID symptoms by half, while tripling use of lower-cost telehealth visits for these patients. Prisma is utilizing Conversa’s automated care programs to augment the care of its patients with diabetes, chronic heart failure, COPD and asthma. Prisma is also using Conversa’s COVID-19 vaccine program.
“It’s no surprise to see Conversa recognized as a leading AI chatbot,” said Dr. Nick Patel, chief digital officer at Prisma Health. “Patients want access to care anytime, anywhere, and providers need an effective and efficient way to monitor, manage and communicate with their patients. Conversa helps Prisma gather health data, analyze it and navigate patients along personalized journeys down evidence-based pathways.”
Growing recognition of Conversa platform
Leading analysts and investors have recognized the impact of Conversa’s platform:
- The UCSF Digital Health Awards honored Conversa Health as the “best remote diagnostics company” for 2020.
- Frost & Sullivan chose Conversa for its North American Visionary Innovation Leadership and Best Practices Award for Patient Care Management.
- Earlier this year, Conversa announced it expanded its Series B to $20 million.
“CB Insights is further validating the importance of automated virtual care as a complementary care delivery model. We’re honored to be identified as a leader in the space,” said Murray Brozinsky, Conversa’s CEO. “Our team is dedicated to helping healthcare organizations increase access to care, enhance the patient experience and improve health outcomes.”